Are you Dr. Lopez?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 89 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
52 Washington Ave
Suite 4
North Haven, CT 06473Phone+1 203-672-2800Fax+1 203-672-2801
Summary
- Dr. Antonio Lopez, MD is a board certified internist in North Haven, Connecticut. He is currently licensed to practice medicine in Connecticut and Louisiana. He is affiliated with Hospital of St Raphael, Yale-New Haven Hospital, and Griffin Hospital.
Education & Training
- Tulane UniversityFellowship, Endocrinology, Diabetes, and Metabolism, 1996 - 1998
- Rutgers Health/New Jersey Medical SchoolResidency, Internal Medicine, 1993 - 1996
- University of Santo TomasClass of 1990
Certifications & Licensure
- CT State Medical License 1997 - 2024
- LA State Medical License 1996 - 1998
- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2012-2013
Publications & Presentations
PubMed
- 528 citationsRituximab Anti-CD20 Monoclonal Antibody Therapy in Non-Hodgkin’s Lymphoma: Safety and Efficacy of Re-TreatmentThomas A. Davis, Antonio J. Grillo-Lopez, Christine A. White, Peter McLaughlin, Myron S. Czuczman
Journal of Clinical Oncology. 2000-09-17 - 441 citationsAssociation of serum Rituximab (IDEC-C2B8) concentration and anti-tumor response in the treatment of recurrent low-grade or follicular non-Hodgkin's lymphomaNeil L. Berinstein, Antonio J. Grillo-Lopez, Christine A. White, I. Bence-Bruckler, David G. Maloney
Annals of Oncology. 1998-09-01 - 2185 citationsRituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.Peter McLaughlin, Antonio J. Grillo-Lopez, Brian K. Link, Ronald Levy, Myron S. Czuczman
Journal of Clinical Oncology. 1998-08-01